BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19566378)

  • 1. Patented small molecules against psoriasis.
    Abdelnoor AM
    Expert Opin Ther Pat; 2009 Aug; 19(8):1057-71. PubMed ID: 19566378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concepts of the mechanisms of action of cyclosporin in psoriasis. A review with guidelines on therapy].
    Mrowietz U
    Hautarzt; 1993 Jun; 44(6):353-60. PubMed ID: 8392987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amygdalin analogs for the treatment of psoriasis.
    Perez JJ
    Future Med Chem; 2013 May; 5(7):799-808. PubMed ID: 23651093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting leukocyte recruitment in the treatment of psoriasis.
    Li YY; Zollner TM; Schön MP
    Clin Dermatol; 2008; 26(5):527-38. PubMed ID: 18755372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis: a fresh look.
    Galadari I; Sharif MO; Galadari H
    Clin Dermatol; 2005; 23(5):491-502. PubMed ID: 16179183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapeutic targets in psoriasis.
    Bayliffe AI; Brigandi RA; Wilkins HJ; Levick MP
    Curr Opin Pharmacol; 2004 Jun; 4(3):306-10. PubMed ID: 15140425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).
    Chiricozzi A; Saraceno R; Novelli L; Fida M; Caso F; Scarpa R; Costa L; Perricone R; Romanelli M; Chimenti S; Chimenti MS
    Expert Opin Ther Pat; 2016 Jul; 26(7):757-66. PubMed ID: 27266423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-signaling molecules in psoriasis pathogenesis: implications for targeted therapy.
    Lin X; Huang T
    Hum Immunol; 2015 Mar; 76(2-3):95-101. PubMed ID: 25636578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of T-lymphocyte mediators in the pathogenesis of psoriasis].
    Kozin VM; Adamenko GP; Bogdanovich LI; Stel'machenok GE
    Vestn Dermatol Venerol; 1987; (7):36-9. PubMed ID: 3499715
    [No Abstract]   [Full Text] [Related]  

  • 10. Plants and plant products with potential antipsoriatic activity--a review.
    Kaur A; Kumar S
    Pharm Biol; 2012 Dec; 50(12):1573-91. PubMed ID: 22971237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phloroglucinol compounds of therapeutic interest: global patent and technology status.
    Singh IP; Sidana J; Bansal P; Foley WJ
    Expert Opin Ther Pat; 2009 Jun; 19(6):847-66. PubMed ID: 19473105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis: new drugs on the horizon?
    Bonney RC
    Am Clin Lab; 2001 Sep; 20(8):30-1. PubMed ID: 11586939
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous leukocyte trafficking and psoriasis.
    Griffiths CE
    Arch Dermatol; 1994 Apr; 130(4):494-9. PubMed ID: 8166488
    [No Abstract]   [Full Text] [Related]  

  • 14. Small Molecules in the Treatment of Psoriasis.
    Torres T; Filipe P
    Drug Dev Res; 2015 Aug; 76(5):215-27. PubMed ID: 26255795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Briakinumab.
    Lima XT; Abuabara K; Kimball AB; Lima HC
    Expert Opin Biol Ther; 2009 Aug; 9(8):1107-13. PubMed ID: 19569977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T.
    Araya E; Rodriguez A; Rubio J; Spada A; Joglar J; Llebaria A; Lagunas C; Fernandez AG; Spisani S; Perez JJ
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1493-6. PubMed ID: 15713414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Targeted against T-cells: immunomodulators in psoriasis].
    Mader U
    Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1640. PubMed ID: 12931726
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
    Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
    J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Options for the treatment of psoriasis: a multifactorial approach.
    van de Kerkhof PC
    Clin Dermatol; 2008; 26(5):419-23. PubMed ID: 18755359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.